New blood test device aims for faster, more accurate results
NCT ID NCT07345091
Summary
This study is testing a new medical device called ABL90 FLEX PLUS HEM that detects hemolysis, which is damage to red blood cells. Researchers will collect blood samples from 95 adults to see how accurately the device identifies different levels of hemolysis compared to standard lab methods. The goal is to validate the device's performance before seeking regulatory approval for wider clinical use.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMOLYSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Bispebjerg Hospital
RECRUITINGCopenhagen, NV, 2400, Denmark
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.